Baitelin Tablets 10/10 mg
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Hwaill Pharmaceutical Co., Ltd.
MFDS item code 201907234 · Approved 2019.10.15
This product's status changed to Expired on 2024.10.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
This medication helps lower total cholesterol, LDL-cholesterol, ApoB protein, and triglycerides while increasing HDL-cholesterol in patients with primary hypercholesterolemia (particularly heterozygous familial and non-familial) and mixed hyperlipidemia. It is also used as an adjunctive therapy in patients with homozygous familial hypercholesterolemia when existing therapies are ineffective. This medication should be used in conjunction with an appropriate diet, and any secondary causes should be checked and treated beforehand. It should be applied cautiously in patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia. Regular monitoring of serum lipid levels during treatment is essential. Overall, this medication is effectively used for improving dyslipidemia and preventing cardiovascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be initiated at 10/10mg once daily. After starting treatment or adjusting the dose, the dose should be adjusted after checking blood lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Use in patients with renal impairment or chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. If higher doses are administered to these patients, use caution and closely monitor them (see 5. General Precautions under Precautions for Use). Use in older adults No dose adjustment is required in older adults. Concomitant use with other drugs (See 6. Drug Interactions under Precautions for Use.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.
This medication is primarily used to lower cholesterol levels and help reduce the risk of cardiovascular disease. While taking this medication, symptoms such as muscle pain or weakness may occur, which could signal serious muscle conditions such as myopathy or rhabdomyolysis, so caution is necessary. The risk of muscle problems may increase, especially when taking high doses or combining with certain other medications. This medication may affect liver function; therefore, patients with liver disease or elevated liver enzyme levels should not take it. Women who are pregnant or lactating should not take this medication, and women of childbearing age should only take it when the possibility of pregnancy is low. Combining this medication with potent CYP3A4 inhibitors such as certain antibiotics, antifungals, and antivirals can be dangerous, so it should not be taken together. Additionally, it should not be combined with drugs like Gemfibrozil, Cyclosporin, or Danazol. During treatment, do not take other medications without consulting a physician, and inform any healthcare provider of this medication when receiving new prescriptions. If symptoms of muscle pain or weakness occur, contact a physician immediately, and regular muscle-related testing is recommended. Elderly patients or those with kidney disease should be particularly cautious when taking this medication, and regular examinations of liver and muscle function are advised. This medication may raise blood sugar levels in some patients; thus, thorough blood sugar management is necessary for those at risk of diabetes. Avoid taking this medication with certain foods like grapefruit juice, as it may increase drug concentration and the risk of side effects. In the case of overdose, there is no specific antidote, so avoid unintentional overdose and seek medical attention immediately if problems arise.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent exposure to air or moisture. It is best to keep the medication at room temperature, between 1 and 30 degrees, avoiding extremely hot or cold environments.
White to pale yellow, biconvex, rectangular tablet
30 tablets/PTP [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Hwaill Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.